Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Targeting innate immunity for tuberculosis vaccination.

Khader SA, Divangahi M, Hanekom W, Hill PC, Maeurer M, Makar KW, Mayer-Barber KD, Mhlanga MM, Nemes E, Schlesinger LS, van Crevel R, Vankalayapati R, Xavier RJ, Netea MG; Bill and Melinda Gates Foundation Collaboration for TB Vaccine Discovery Innate Immunity Working Group18.

J Clin Invest. 2019 Sep 3;129(9):3482-3491. doi: 10.1172/JCI128877. Review.

2.

Tackling diabetes mellitus and tuberculosis: a new Union guide on the management of diabetes-tuberculosis.

Lin Y, Harries AD, Kumar AMV, Critchley JA, van Crevel R, Owiti P, Dlodlo RA, Kapur A.

Int J Tuberc Lung Dis. 2019 Jul 1;23(7):771-772. doi: 10.5588/ijtld.19.0119. No abstract available.

PMID:
31439106
3.

IL-32 and its splice variants are associated with protection against Mycobacterium tuberculosis infection and skewing of Th1/Th17 cytokines.

Koeken VACM, Verrall AJ, Ardiansyah E, Apriani L, Dos Santos JC, Kumar V, Alisjahbana B, Hill PC, Joosten LAB, van Crevel R, van Laarhoven A.

J Leukoc Biol. 2019 Aug 4. doi: 10.1002/JLB.4AB0219-071R. [Epub ahead of print]

PMID:
31378983
4.

Management of patients with multidrug-resistant tuberculosis.

Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K.

Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622.

PMID:
31315696
5.

Early Clearance of Mycobacterium tuberculosis: The INFECT Case Contact Cohort Study in Indonesia.

Verrall AJ, Alisjahbana B, Apriani L, Novianty N, Nurani AC, van Laarhoven A, Ussher JE, Indrati A, Ruslami R, Netea MG, Sharples K, van Crevel R, Hill PC.

J Infect Dis. 2019 Jul 12. pii: jiz168. doi: 10.1093/infdis/jiz168. [Epub ahead of print]

PMID:
31298280
6.

Reply to Yates and Barr.

Ugarte-Gil C, Pearson F, Moore D, Critchley J, van Crevel R.

Clin Infect Dis. 2019 May 24. pii: ciz434. doi: 10.1093/cid/ciz434. [Epub ahead of print] No abstract available.

PMID:
31247066
7.

Are there differences in HIV retention in care between female and male patients in Indonesia? A multi-state analysis of a retrospective cohort study.

Rahmalia A, Price MH, Hartantri Y, Alisjahbana B, Wisaksana R, van Crevel R, van der Ven AJAM.

PLoS One. 2019 Jun 25;14(6):e0218781. doi: 10.1371/journal.pone.0218781. eCollection 2019.

8.

Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatment.

Stemkens R, Litjens CHC, Dian S, Ganiem AR, Yunivita V, van Crevel R, Te Brake LHM, Ruslami R, Aarnoutse RE.

Int J Antimicrob Agents. 2019 Sep;54(3):371-374. doi: 10.1016/j.ijantimicag.2019.06.010. Epub 2019 Jun 14.

PMID:
31202922
9.

Non-specific effects of BCG vaccine on viral infections.

Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG.

Clin Microbiol Infect. 2019 May 2. pii: S1198-743X(19)30197-1. doi: 10.1016/j.cmi.2019.04.020. [Epub ahead of print] Review.

PMID:
31055165
10.

Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses.

Verrall AJ, Schneider M, Alisjahbana B, Apriani L, van Laarhoven A, Koeken VACM, van Dorp S, Diadani E, Utama F, Hannaway RF, Indrati A, Netea MG, Sharples K, Hill PC, Ussher JE, van Crevel R.

J Infect Dis. 2019 Apr 8. pii: jiz147. doi: 10.1093/infdis/jiz147. [Epub ahead of print]

PMID:
30958547
11.

Diabetes mellitus among pulmonary tuberculosis patients from four TB-endemic countries: the TANDEM study.

Ugarte-Gil C, Alisjahbana B, Ronacher K, Riza AL, Koesoemadinata RC, Malherbe ST, Cioboata R, Llontop JC, Kleynhans L, Lopez S, Santoso P, Marius C, Villaizan K, Ruslami R, Walzl G, Panduru NM, Dockrell HM, Hill PC, Mc Allister S, Pearson F, Moore DAJ, Critchley JA, van Crevel R; TANDEM Consortium.

Clin Infect Dis. 2019 Apr 8. pii: ciz284. doi: 10.1093/cid/ciz284. [Epub ahead of print]

PMID:
30958536
12.

Carbamazepine intervention in a patient with efavirenz-induced liver injury.

Jacobs TG, Burger DM, Pranger AD, Khoo SH, Drenth JPH, van Crevel R.

AIDS. 2019 May 1;33(6):1097-1098. doi: 10.1097/QAD.0000000000002116. No abstract available.

PMID:
30946165
13.

INTERACTING NON-SPECIFIC IMMUNOLOGICAL EFFECTS OF BCG AND Tdapf VACCINATIONS: AN EXPLORATIVE RANDOMIZED TRIAL.

Blok BA, de Bree LCJ, Diavatopoulos DA, Langereis JD, Joosten LAB, Aaby P, van Crevel R, Benn CS, Netea MG.

Clin Infect Dis. 2019 Mar 28. pii: ciz246. doi: 10.1093/cid/ciz246. [Epub ahead of print]

PMID:
30919883
14.

Point of care HbA1c level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countries.

Huangfu P, Laurence YV, Alisjahbana B, Ugarte-Gil C, Riza AL, Walzl G, Ruslami R, Moore DAJ, Ioana M, McAllister S, Ronacher K, Koesoemadinata RC, Grint D, Kerry S, Coronel J, Malherbe ST, Griffiths U, Dockrell HM, Hill PC, van Crevel R, Pearson F, Critchley JA.

Int J Tuberc Lung Dis. 2019 Mar 1;23(3):283-292. doi: 10.5588/ijtld.18.0359.

PMID:
30871659
15.

High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.

Seijger C, Hoefsloot W, Bergsma-de Guchteneire I, Te Brake L, van Ingen J, Kuipers S, van Crevel R, Aarnoutse R, Boeree M, Magis-Escurra C.

PLoS One. 2019 Mar 14;14(3):e0213718. doi: 10.1371/journal.pone.0213718. eCollection 2019.

16.

Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.

Soeroto AY, Lestari BW, Santoso P, Chaidir L, Andriyoko B, Alisjahbana B, van Crevel R, Hill PC.

PLoS One. 2019 Feb 28;14(2):e0213017. doi: 10.1371/journal.pone.0213017. eCollection 2019.

17.

Trained innate immunity and resistance to Mycobacterium tuberculosis infection.

Koeken VACM, Verrall AJ, Netea MG, Hill PC, van Crevel R.

Clin Microbiol Infect. 2019 Feb 23. pii: S1198-743X(19)30081-3. doi: 10.1016/j.cmi.2019.02.015. [Epub ahead of print] Review.

PMID:
30807849
18.

Outcomes of controlled human malaria infection after BCG vaccination.

Walk J, de Bree LCJ, Graumans W, Stoter R, van Gemert GJ, van de Vegte-Bolmer M, Teelen K, Hermsen CC, Arts RJW, Behet MC, Keramati F, Moorlag SJCFM, Yang ASP, van Crevel R, Aaby P, de Mast Q, van der Ven AJAM, Stabell Benn C, Netea MG, Sauerwein RW.

Nat Commun. 2019 Feb 20;10(1):874. doi: 10.1038/s41467-019-08659-3.

19.

Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study.

Arends RM, Nelwan EJ, Soediro R, van Crevel R, Alisjahbana B, Pohan HT, von Borries AKL, Schene AH, van der Ven AJAM, Schellekens AFA.

PLoS One. 2019 Feb 15;14(2):e0207970. doi: 10.1371/journal.pone.0207970. eCollection 2019.

20.

Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa.

Hopman J, Meijer C, Kenters N, Coolen JPM, Ghamati MR, Mehtar S, van Crevel R, Morshuis WJ, Verhagen AFTM, van den Heuvel MM, Voss A, Wertheim HFL.

JAMA Netw Open. 2019 Feb 1;2(2):e187665. doi: 10.1001/jamanetworkopen.2018.7665.

21.

Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects.

Lachmandas E, Eckold C, Böhme J, Koeken VACM, Marzuki MB, Blok B, Arts RJW, Chen J, Teng KWW, Ratter J, Smolders EJ, Van den Heuvel C, Stienstra R, Dockrell HM, Newell E, Netea MG, Singhal A, Cliff JM, Van Crevel R.

J Infect Dis. 2019 Jun 5;220(1):139-150. doi: 10.1093/infdis/jiz064.

22.

Opposite effects of Vaccinia and modified Vaccinia Ankara on trained immunity.

Blok BA, Jensen KJ, Aaby P, Fomsgaard A, van Crevel R, Benn CS, Netea MG.

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):449-456. doi: 10.1007/s10096-018-03449-z. Epub 2019 Feb 5.

PMID:
30719592
23.

Immune cell characteristics and cytokine responses in adult HIV-negative tuberculous meningitis: an observational cohort study.

van Laarhoven A, Dian S, van Dorp S, Purnama F, Koeken VACM, Diandini E, Utami F, Livia R, Apriani L, Ardiansyah E, Ter Horst R, Netea MG, Achmad TH, Hill PC, Ruslami R, Alisjahbana B, Ussher JE, Indrati A, Verrall A, Ganiem AR, van Crevel R.

Sci Rep. 2019 Jan 29;9(1):884. doi: 10.1038/s41598-018-36696-3.

24.

Barriers to diagnosis and management of CNS infections in Indonesia.

Imran D, Satiti S, Sugianto P, Estiasari R, Maharani K, Pangeran D, Andini PW, Munir B, Mawuntu AHP, Susilawathi NM, Ritarwan K, Hartanto OS, Frida M, Ganiem AR, Gunawan D, Dian S, Sudewi AAR, van Crevel R.

Neurology. 2019 Jan 8;92(2):104-106. doi: 10.1212/WNL.0000000000006732. No abstract available.

PMID:
30617169
25.

Clinical management of combined tuberculosis and diabetes.

van Crevel R, Koesoemadinata R, Hill PC, Harries AD.

Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1404-1410. doi: 10.5588/ijtld.18.0340. Review.

PMID:
30606312
26.

Presentation, etiology, and outcome of brain infections in an Indonesian hospital: A cohort study.

Imran D, Estiasari R, Maharani K, Sucipto, Lestari DC, Yunus RE, Yunihastuti E, Karyadi TH, Oei D, Timan IS, Wulandari D, Wahyuningsih R, Adawiyah R, Kurniawan A, Mulyadi R, Karuniawati A, Jaya UA, Safari D, van Laarhoven A, Alisjahbana B, Dian S, Chaidir L, Ganiem AR, Lastri DN, Aye Myint KS, van Crevel R.

Neurol Clin Pract. 2018 Oct;8(5):379-388. doi: 10.1212/CPJ.0000000000000517.

PMID:
30564491
27.

Role of Glutamine Metabolism in Host Defense Against Mycobacterium tuberculosis Infection.

Koeken VACM, Lachmandas E, Riza A, Matzaraki V, Li Y, Kumar V, Oosting M, Joosten LAB, Netea MG, van Crevel R.

J Infect Dis. 2019 Apr 19;219(10):1662-1670. doi: 10.1093/infdis/jiy709.

PMID:
30541099
28.

Intensified antibiotic treatment of tuberculosis meningitis.

Cresswell FV, Te Brake L, Atherton R, Ruslami R, Dooley KE, Aarnoutse R, Van Crevel R.

Expert Rev Clin Pharmacol. 2019 Mar;12(3):267-288. doi: 10.1080/17512433.2019.1552831. Epub 2019 Feb 12. Review.

PMID:
30474434
29.

Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa.

Grint D, Alisjhabana B, Ugarte-Gil C, Riza AL, Walzl G, Pearson F, Ruslami R, Moore DAJ, Ioana M, McAllister S, Ronacher K, Koeseomadinata RC, Kerry-Barnard SR, Coronel J, Malherbe ST, Dockrell HM, Hill PC, Van Crevel R, Critchley JA; TANDEM consortium.

Bull World Health Organ. 2018 Nov 1;96(11):738-749. doi: 10.2471/BLT.17.206227. Epub 2018 Aug 27.

30.

H4:IC31 Vaccine or BCG Revaccination for Tuberculosis.

de Bree C, van Crevel R, Netea MG.

N Engl J Med. 2018 Nov 15;379(20):1969. doi: 10.1056/NEJMc1811046. No abstract available.

PMID:
30428296
31.

Corrigendum: Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice.

de Bree LCJ, Marijnissen RJ, Kel JM, Rosendahl Huber SK, Aaby P, Benn CS, Wijnands MVW, Diavatopoulos DA, van Crevel R, Joosten LAB, Netea MG, Dulos J.

Front Immunol. 2018 Oct 25;9:2471. doi: 10.3389/fimmu.2018.02471. eCollection 2018.

32.

Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial.

Donovan J, Phu NH, Mai NTH, Dung LT, Imran D, Burhan E, Ngoc LHB, Bang ND, Giang DC, Ha DTM, Day J, Thao LTP, Thuong NT, Vien NN, Geskus RB, Wolbers M, Hamers RL, van Crevel R, Nursaya M, Maharani K, Hien TT, Baird K, Lan NH, Kestelyn E, Chau NVV, Thwaites GE.

Version 2. Wellcome Open Res. 2018 Jun 20 [revised 2018 Jan 1];3:31. doi: 10.12688/wellcomeopenres.14006.2. eCollection 2018.

33.

Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis.

Dian S, Yunivita V, Ganiem AR, Pramaesya T, Chaidir L, Wahyudi K, Achmad TH, Colbers A, Te Brake L, van Crevel R, Ruslami R, Aarnoutse R.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01014-18. doi: 10.1128/AAC.01014-18. Print 2018 Dec.

34.

Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients.

Te Brake LHM, Yunivita V, Livia R, Soetedjo N, van Ewijk-Beneken Kolmer E, Koenderink JB, Burger DM, Santoso P, van Crevel R, Alisjahbana B, Aarnoutse RE, Ruslami R; on behalf of the TANDEM Consortium.

Clin Pharmacol Ther. 2019 Mar;105(3):730-737. doi: 10.1002/cpt.1232. Epub 2018 Oct 29.

35.

Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl-Neelsen stain, GeneXpert, and culture of cerebrospinal fluid.

Heemskerk AD, Donovan J, Thu DDA, Marais S, Chaidir L, Dung VTM, Centner CM, Ha VTN, Annisa J, Dian S, Bovijn L, Mai NTH, Phu NH, Chau NVV, Ganiem AR, Van CT, Geskus RB, Thuong NTT, Ruslami R, Meintjes G, van Crevel R, Wilkinson RJ, Thwaites GE.

J Infect. 2018 Dec;77(6):509-515. doi: 10.1016/j.jinf.2018.09.003. Epub 2018 Sep 12.

36.

T Cell Metabolism Has Evolved to Tolerate Tuberculosis.

Koeken VACM, van Crevel R, Netea MG.

Cell Metab. 2018 Sep 4;28(3):332-333. doi: 10.1016/j.cmet.2018.08.015.

37.

Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.

Chaidir L, Ruesen C, Dutilh BE, Ganiem AR, Andryani A, Apriani L, Huynen MA, Ruslami R, Hill PC, van Crevel R, Alisjahbana B.

J Glob Antimicrob Resist. 2019 Mar;16:170-177. doi: 10.1016/j.jgar.2018.08.018. Epub 2018 Aug 29.

PMID:
30172045
38.

The impact of sex hormones on BCG-induced trained immunity.

de Bree LCJ, Janssen R, Aaby P, van Crevel R, Joosten LAB, Benn CS, Netea MG.

J Leukoc Biol. 2018 Sep;104(3):573-578. doi: 10.1002/JLB.5MA0118-027R.

PMID:
30153369
39.

A switch to a raltegravir containing regimen does not lower platelet reactivity in HIV-infected individuals.

van der Heijden WA, van Crevel R, de Groot PG, Urbanus RT, Koenen HJPM, Bosch M, Keuter M, van der Ven AJ, de Mast Q.

AIDS. 2018 Nov 13;32(17):2469-2475. doi: 10.1097/QAD.0000000000001993.

PMID:
30134289
40.

Disease characteristics and treatment of patients with diabetes mellitus attending government health services in Indonesia, Peru, Romania and South Africa.

Soetedjo NNM, McAllister SM, Ugarte-Gil C, Firanescu AG, Ronacher K, Alisjahbana B, Costache AL, Zubiate C, Malherbe ST, Koesoemadinata RC, Laurence YV, Pearson F, Kerry-Barnard S, Ruslami R, Moore DAJ, Ioana M, Kleynhans L, Permana H, Hill PC, Mota M, Walzl G, Dockrell HM, Critchley JA, van Crevel R; TANDEM Consortium.

Trop Med Int Health. 2018 Oct;23(10):1118-1128. doi: 10.1111/tmi.13137. Epub 2018 Sep 10.

PMID:
30106222
41.

Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus.

Koesoemadinata RC, Kranzer K, Livia R, Susilawati N, Annisa J, Soetedjo NNM, Ruslami R, Philipsen R, van Ginneken B, Soetikno RD, van Crevel R, Alisjahbana B, Hill PC.

Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1088-1094. doi: 10.5588/ijtld.17.0827.

PMID:
30092877
42.

Non-specific effects of vaccines: Current evidence and potential implications.

de Bree LCJ, Koeken VACM, Joosten LAB, Aaby P, Benn CS, van Crevel R, Netea MG.

Semin Immunol. 2018 Oct;39:35-43. doi: 10.1016/j.smim.2018.06.002. Epub 2018 Jul 11. Review.

PMID:
30007489
43.

Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania.

Ruesen C, Riza AL, Florescu A, Chaidir L, Editoiu C, Aalders N, Nicolosu D, Grecu V, Ioana M, van Crevel R, van Ingen J.

Sci Rep. 2018 Jun 26;8(1):9676. doi: 10.1038/s41598-018-27962-5.

44.

Predicting Mortality of Tuberculous Meningitis.

Dian S, Rahmadi R, van Laarhoven A, Ganiem AR, van Crevel R.

Clin Infect Dis. 2018 Nov 28;67(12):1954-1955. doi: 10.1093/cid/ciy445. No abstract available.

PMID:
29860408
45.

Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice.

de Bree LCJ, Marijnissen RJ, Kel JM, Rosendahl Huber SK, Aaby P, Benn CS, Wijnands MVW, Diavatopoulos DA, van Crevel R, Joosten LAB, Netea MG, Dulos J.

Front Immunol. 2018 Apr 30;9:869. doi: 10.3389/fimmu.2018.00869. eCollection 2018. Erratum in: Front Immunol. 2018 Oct 25;9:2471.

46.

Tissue Metabolic Changes Drive Cytokine Responses to Mycobacterium tuberculosis.

Lachmandas E, Rios-Miguel AB, Koeken VACM, van der Pasch E, Kumar V, Matzaraki V, Li Y, Oosting M, Joosten LAB, Notebaart RA, Noursadeghi M, Netea MG, van Crevel R, Pollara G.

J Infect Dis. 2018 Jun 5;218(1):165-170. doi: 10.1093/infdis/jiy173.

47.

Neuromarker Levels Also Predict Mortality in Adult Tuberculous Meningitis.

van Laarhoven A, Koeken VACM, Dian S, Ganiem AR, van Crevel R.

Clin Infect Dis. 2018 Aug 1;67(4):642-643. doi: 10.1093/cid/ciy126. No abstract available.

PMID:
29617975
48.

Closing the gap in surveillance of tuberculosis and HIV co-infection, and the need for clinician-public health alliances.

de Vries G, van den Hof S, Op de Coul E, van Crevel R.

Eur Respir J. 2018 Mar 22;51(3). pii: 1702671. doi: 10.1183/13993003.02671-2017. Print 2018 Mar. No abstract available.

49.

Mycobacterial growth inhibition is associated with trained innate immunity.

Joosten SA, van Meijgaarden KE, Arend SM, Prins C, Oftung F, Korsvold GE, Kik SV, Arts RJ, van Crevel R, Netea MG, Ottenhoff TH.

J Clin Invest. 2018 May 1;128(5):1837-1851. doi: 10.1172/JCI97508. Epub 2018 Apr 3.

50.

Microbiological diagnosis of adult tuberculous meningitis in a ten-year cohort in Indonesia.

Chaidir L, Annisa J, Dian S, Parwati I, Alisjahbana A, Purnama F, van der Zanden A, Ganiem AR, van Crevel R.

Diagn Microbiol Infect Dis. 2018 May;91(1):42-46. doi: 10.1016/j.diagmicrobio.2018.01.004. Epub 2018 Jan 9.

PMID:
29444749

Supplemental Content

Loading ...
Support Center